Cytokine therapies: novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009]
Saved in:
| Other Authors: | |
|---|---|
| Format: | Conference Proceeding Book |
| Language: | English |
| Published: |
Boston, Mass.
Blackwell
2009
|
| Series: | Annals of the New York Academy of Sciences
1182 |
| Subjects: | |
| Online Access: | Inhaltsverzeichnis |
| Physical Description: | VI, 160 S. Ill., graph. Darst. |
| ISBN: | 9781573317832 1573317837 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV036050201 | ||
| 003 | DE-604 | ||
| 005 | 20110804 | ||
| 007 | t | ||
| 008 | 100224s2009 ad|| |||| 10||| eng d | ||
| 020 | |a 9781573317832 |9 978-1-57331-783-2 | ||
| 020 | |a 1573317837 |9 1-57331-783-7 | ||
| 035 | |a (OCoLC)643998703 | ||
| 035 | |a (DE-599)HBZHT016205812 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-20 |a DE-355 | ||
| 084 | |a XD 3215 |0 (DE-625)152553:12921 |2 rvk | ||
| 245 | 1 | 0 | |a Cytokine therapies |b novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009] |c ed. by Raymond P. Donnelly |
| 264 | 1 | |a Boston, Mass. |b Blackwell |c 2009 | |
| 300 | |a VI, 160 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Annals of the New York Academy of Sciences |v 1182 | |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Interferon |0 (DE-588)4130836-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Interleukine |0 (DE-588)4162019-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Cytokine |0 (DE-588)4205701-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 2009 |z New York, NY |2 gnd-content | |
| 689 | 0 | 0 | |a Cytokine |0 (DE-588)4205701-2 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Interferon |0 (DE-588)4130836-0 |D s |
| 689 | 1 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a Interleukine |0 (DE-588)4162019-7 |D s |
| 689 | 2 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 2 | |C b |5 DE-604 | |
| 700 | 1 | |a Donnelly, Raymond P. |4 edt | |
| 711 | 2 | |a Conference Cytokine Therapies: Novel Approaches for Clinical Indications |d 2009 |c New York, NY |j Sonstige |0 (DE-588)6529477-4 |4 oth | |
| 830 | 0 | |a Annals of the New York Academy of Sciences |v 1182 |w (DE-604)BV002532608 |9 1182 | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018941900&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-018941900 | ||
Record in the Search Index
| _version_ | 1804141087292391424 |
|---|---|
| adam_text | Titel: Cytokine therapies
Autor: Donnelly, Raymond P.
Jahr: 2009
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
Volume 1182
Cytokine Therapies
Approaches for Clinical Indications
Editor
Raymond P. Donnelly
This volume presents manuscripts stemming from the conference Cytokine Therapies:
Novel Approaches for Clinical Indications, held at the New York Academy of Sciences
Conference Center on March 26-27, 2009, and cosponsored by the U.S. Food and
Drug Administration. Sponsors were BioLegend, Invitrogen, and PBL InterferonSource.
This activity was supported by educational donations provided by Abbott Laboratories,
Amgen, Inc.; Celgene Corporation; and Centocor Research and Development, Inc.
CONTENTS
An Overview of Cytokines and Cytokine Antagonists as Therapeutic Agents.
By Raymond P. Donnelly, Howard A. Young, and Amy S. Rosenberg....... 1
Pharmacologic Administration of Interleukin-2: Inducing a Systemic Autophagic
Syndrome? By Antonio Romo de Vivar Chavez, William Buchser, Per H.
Basse, Xiaoyan Liang, Leonard J. Appleman, Jodi K. Maranchie, Herbert
Zeh, Michael E. de Vera, and Michael T. Lotze .......................... 14
Perspective on Potential Clinical Applications of Recombinant Human
Interleukin-7. By Claude Sportes, Ronald E. Gress, and Crystal L.
Mackall............................................................... 28
Immune Modulation with Interleukin-21. By Neela S. Bhave and William E.
Carson III ............................................................ 39
Clinical and Immunologic Basis of Interferon Therapy in Melanoma. By Ahmad
A. Tarhini and John M. Kirkwood ...................................... 47
Heterogeneous, Longitudinally Stable Molecular Signatures in Response to
Interferon-^. By M. R. Sandhya Rani, Yaomin Xu,Jar-chi Lee, Jennifer
Shrock, Anupamajosyula, Joerg Schlaak, Swathi Chakraborthv; Xieja,
Richard M. Ransohoff, and Richard A. Rudick........................... 58
Clinical Use of Interferon-y. By Catriona H.T. Miller, Stephen G. Maher, and
Howard A. Young ..................................................... 69
Interferon Lambda as a Potential New Therapeutic for Hepatitis C.
By Dennis M. Miller, Kevin M. Klucher, Jeremy A. Freeman, Diana F.
Hausman, David Fontana, and Doug E. Williams......................... 80
vi Annals of the New York Academy of Sciences
Cytokines as Targets for Ajiti-inflamrnatory Agents. By Larry W. Moreland..... 88
Ustekinumab: Lessons Learned from Targeting Interleukin-12/23p40 in
Immune-Mediated Diseases. By Michael Elliott, Jacqueline Benson, Marion
Blank, Carrie Brodmerkel, Daniel Baker, Kristin Ruley Sharpies, and
Philippe Szapary ...................................................... 97
Blocking Interleukin-1 in Rheumatic Diseases: Its Initial Disappointments and
Recent Successes in the Treatment of Autoinflammatory Diseases.
By Raphaela Goldbach-Mansky......................................... Ill
Rilonacept?CAPS and Beyond: A Scientific Journey. By Neil Stahl, Allen Radin,
and Scott Mellis ....................................................... 124
Actobiotics? as a Novel Method for Cytokine Delivery: The Interleukin-10
Case. By Lothar Steidler, Pieter Rottiers, and Bernard Coulie.............. 135
Hurdles and Leaps for Protein Therapeutics: Cytokines and Inflammation.
By Steven Kozlowski, Barry Cherney, and Raymond P. Donnelly........... 146
The New York Academy of Sciences believes it has a responsibility to provide an open forum for
discussion of scientific questions. The positions taken by the participants in the reported conferences are
their own and not necessarily those of the Academy. The Academy has no intent to influence legislation
by providing such forums.
|
| any_adam_object | 1 |
| author2 | Donnelly, Raymond P. |
| author2_role | edt |
| author2_variant | r p d rp rpd |
| author_facet | Donnelly, Raymond P. |
| building | Verbundindex |
| bvnumber | BV036050201 |
| classification_rvk | XD 3215 |
| ctrlnum | (OCoLC)643998703 (DE-599)HBZHT016205812 |
| discipline | Medizin |
| format | Conference Proceeding Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02315nam a2200493 cb4500</leader><controlfield tag="001">BV036050201</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20110804 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">100224s2009 ad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781573317832</subfield><subfield code="9">978-1-57331-783-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1573317837</subfield><subfield code="9">1-57331-783-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)643998703</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)HBZHT016205812</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XD 3215</subfield><subfield code="0">(DE-625)152553:12921</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cytokine therapies</subfield><subfield code="b">novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009]</subfield><subfield code="c">ed. by Raymond P. Donnelly</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston, Mass.</subfield><subfield code="b">Blackwell</subfield><subfield code="c">2009</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">VI, 160 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Annals of the New York Academy of Sciences</subfield><subfield code="v">1182</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Interferon</subfield><subfield code="0">(DE-588)4130836-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Interleukine</subfield><subfield code="0">(DE-588)4162019-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytokine</subfield><subfield code="0">(DE-588)4205701-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">2009</subfield><subfield code="z">New York, NY</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Cytokine</subfield><subfield code="0">(DE-588)4205701-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Interferon</subfield><subfield code="0">(DE-588)4130836-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Interleukine</subfield><subfield code="0">(DE-588)4162019-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Donnelly, Raymond P.</subfield><subfield code="4">edt</subfield></datafield><datafield tag="711" ind1="2" ind2=" "><subfield code="a">Conference Cytokine Therapies: Novel Approaches for Clinical Indications</subfield><subfield code="d">2009</subfield><subfield code="c">New York, NY</subfield><subfield code="j">Sonstige</subfield><subfield code="0">(DE-588)6529477-4</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Annals of the New York Academy of Sciences</subfield><subfield code="v">1182</subfield><subfield code="w">(DE-604)BV002532608</subfield><subfield code="9">1182</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018941900&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-018941900</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift 2009 New York, NY gnd-content |
| genre_facet | Konferenzschrift 2009 New York, NY |
| id | DE-604.BV036050201 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T22:10:18Z |
| institution | BVB |
| institution_GND | (DE-588)6529477-4 |
| isbn | 9781573317832 1573317837 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-018941900 |
| oclc_num | 643998703 |
| open_access_boolean | |
| owner | DE-12 DE-20 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-20 DE-355 DE-BY-UBR |
| physical | VI, 160 S. Ill., graph. Darst. |
| publishDate | 2009 |
| publishDateSearch | 2009 |
| publishDateSort | 2009 |
| publisher | Blackwell |
| record_format | marc |
| series | Annals of the New York Academy of Sciences |
| series2 | Annals of the New York Academy of Sciences |
| spelling | Cytokine therapies novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009] ed. by Raymond P. Donnelly Boston, Mass. Blackwell 2009 VI, 160 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Annals of the New York Academy of Sciences 1182 Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Interferon (DE-588)4130836-0 gnd rswk-swf Interleukine (DE-588)4162019-7 gnd rswk-swf Cytokine (DE-588)4205701-2 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 2009 New York, NY gnd-content Cytokine (DE-588)4205701-2 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Interferon (DE-588)4130836-0 s Interleukine (DE-588)4162019-7 s b DE-604 Donnelly, Raymond P. edt Conference Cytokine Therapies: Novel Approaches for Clinical Indications 2009 New York, NY Sonstige (DE-588)6529477-4 oth Annals of the New York Academy of Sciences 1182 (DE-604)BV002532608 1182 HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018941900&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Cytokine therapies novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009] Annals of the New York Academy of Sciences Pharmakotherapie (DE-588)4076066-2 gnd Interferon (DE-588)4130836-0 gnd Interleukine (DE-588)4162019-7 gnd Cytokine (DE-588)4205701-2 gnd |
| subject_GND | (DE-588)4076066-2 (DE-588)4130836-0 (DE-588)4162019-7 (DE-588)4205701-2 (DE-588)1071861417 |
| title | Cytokine therapies novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009] |
| title_auth | Cytokine therapies novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009] |
| title_exact_search | Cytokine therapies novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009] |
| title_full | Cytokine therapies novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009] ed. by Raymond P. Donnelly |
| title_fullStr | Cytokine therapies novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009] ed. by Raymond P. Donnelly |
| title_full_unstemmed | Cytokine therapies novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009] ed. by Raymond P. Donnelly |
| title_short | Cytokine therapies |
| title_sort | cytokine therapies novel approaches for clinical indications manuscripts stemming from the conference cytokine therapies novel approaches for clinical indications held at the new york academy of sciences conference center on march 26 27 2009 |
| title_sub | novel approaches for clinical indications ; [manuscripts stemming from the Conference "Cytokine Therapies: Novel Approaches for Clinical Indications," held at the New York Academy of Sciences Conference Center on March 26 - 27, 2009] |
| topic | Pharmakotherapie (DE-588)4076066-2 gnd Interferon (DE-588)4130836-0 gnd Interleukine (DE-588)4162019-7 gnd Cytokine (DE-588)4205701-2 gnd |
| topic_facet | Pharmakotherapie Interferon Interleukine Cytokine Konferenzschrift 2009 New York, NY |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018941900&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV002532608 |
| work_keys_str_mv | AT donnellyraymondp cytokinetherapiesnovelapproachesforclinicalindicationsmanuscriptsstemmingfromtheconferencecytokinetherapiesnovelapproachesforclinicalindicationsheldatthenewyorkacademyofsciencesconferencecenteronmarch26272009 AT conferencecytokinetherapiesnovelapproachesforclinicalindicationsnewyorkny cytokinetherapiesnovelapproachesforclinicalindicationsmanuscriptsstemmingfromtheconferencecytokinetherapiesnovelapproachesforclinicalindicationsheldatthenewyorkacademyofsciencesconferencecenteronmarch26272009 |